Managing anticoagulation and antiplatelet medications in GI endoscopy: a survey comparing the East and the West

Sun Young Lee, Shou jiang Tang, Don C. Rockey, Douglas Weinstein, Luis Lara, Jayaprakash Sreenarasimhaiah, Kyoo Wan Choi

Research output: Contribution to journalArticle

54 Citations (Scopus)

Abstract

Background: Anticoagulation and antiplatelet medications may potentiate GI bleeding, and their use may lead to an increased need for a GI endoscopy. We hypothesized that there might be different practice patterns among international endoscopists. Objective: To explore the differences in management practices for patients who receive anticoagulation and antiplatelet medications from Eastern and Western endoscopists. Design: International survey study. Setting: Academic medical centers and private clinics. Subjects: Members of the American Society for Gastrointestinal Endoscopy (ASGE) in Eastern (Korea, Japan, China, India, Thailand, Singapore, Malaysia, and Philippines) and Western (United States and Canada) countries were invited to complete a Web-site-based questionnaire. In addition, the questionnaire was sent to university hospitals in South Korea and academic institutions in the United States. Methods: A survey was administered that contained detailed questions about the use of an endoscopy in patients on anticoagulation and antiplatelet medications. Main Outcome Measurements: Different opinions and clinical practice patterns regarding the use of anticoagulation and antiplatelet medications by Eastern and Western endoscopists. Results: A total of 105 Eastern and 106 Western endoscopists completed the survey. Western endoscopists experienced more instances of procedure-related bleeding (P = .003) and thromboembolism after withdrawal of medications (P = .016). Eastern endoscopists restarted medications later (1-3 days) than Western endoscopists after a biopsy (same day) (P < .001). Eastern endoscopists withdrew aspirin for more than 7 days before a polypectomy and then restarted it 1 to 3 days after a polypectomy, whereas Western endoscopists performed a polypectomy without withdrawing aspirin (P < .001). ASGE guidelines were followed less often by Eastern than by Western endoscopists (P < .001). Limitations: Low response rate, heterogeneity of the sample, and recall bias. Conclusions: The opinions and clinical practice patterns for the management of anticoagulation and antiplatelet medications differed significantly between Eastern and Western endoscopists. The lack of uniformity in practice patterns suggests that more data and better education are required in the area of GI endoscopy for patients on anticoagulation and antiplatelet medications, particularly given that individual patient characteristics may be associated with unique types of complications.

Original languageEnglish (US)
Pages (from-to)1076-1081
Number of pages6
JournalGastrointestinal Endoscopy
Volume67
Issue number7
DOIs
StatePublished - Jun 2008

Fingerprint

Endoscopy
Physicians' Practice Patterns
Gastrointestinal Endoscopy
Practice Management
Aspirin
Hemorrhage
Republic of Korea
Philippines
Malaysia
Singapore
Thromboembolism
Thailand
Korea
Canada
India
China
Japan
Surveys and Questionnaires
Guidelines
Biopsy

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Managing anticoagulation and antiplatelet medications in GI endoscopy : a survey comparing the East and the West. / Lee, Sun Young; Tang, Shou jiang; Rockey, Don C.; Weinstein, Douglas; Lara, Luis; Sreenarasimhaiah, Jayaprakash; Choi, Kyoo Wan.

In: Gastrointestinal Endoscopy, Vol. 67, No. 7, 06.2008, p. 1076-1081.

Research output: Contribution to journalArticle

Lee, Sun Young ; Tang, Shou jiang ; Rockey, Don C. ; Weinstein, Douglas ; Lara, Luis ; Sreenarasimhaiah, Jayaprakash ; Choi, Kyoo Wan. / Managing anticoagulation and antiplatelet medications in GI endoscopy : a survey comparing the East and the West. In: Gastrointestinal Endoscopy. 2008 ; Vol. 67, No. 7. pp. 1076-1081.
@article{c4926dc098ad4c3bb2cfc9605fb9d583,
title = "Managing anticoagulation and antiplatelet medications in GI endoscopy: a survey comparing the East and the West",
abstract = "Background: Anticoagulation and antiplatelet medications may potentiate GI bleeding, and their use may lead to an increased need for a GI endoscopy. We hypothesized that there might be different practice patterns among international endoscopists. Objective: To explore the differences in management practices for patients who receive anticoagulation and antiplatelet medications from Eastern and Western endoscopists. Design: International survey study. Setting: Academic medical centers and private clinics. Subjects: Members of the American Society for Gastrointestinal Endoscopy (ASGE) in Eastern (Korea, Japan, China, India, Thailand, Singapore, Malaysia, and Philippines) and Western (United States and Canada) countries were invited to complete a Web-site-based questionnaire. In addition, the questionnaire was sent to university hospitals in South Korea and academic institutions in the United States. Methods: A survey was administered that contained detailed questions about the use of an endoscopy in patients on anticoagulation and antiplatelet medications. Main Outcome Measurements: Different opinions and clinical practice patterns regarding the use of anticoagulation and antiplatelet medications by Eastern and Western endoscopists. Results: A total of 105 Eastern and 106 Western endoscopists completed the survey. Western endoscopists experienced more instances of procedure-related bleeding (P = .003) and thromboembolism after withdrawal of medications (P = .016). Eastern endoscopists restarted medications later (1-3 days) than Western endoscopists after a biopsy (same day) (P < .001). Eastern endoscopists withdrew aspirin for more than 7 days before a polypectomy and then restarted it 1 to 3 days after a polypectomy, whereas Western endoscopists performed a polypectomy without withdrawing aspirin (P < .001). ASGE guidelines were followed less often by Eastern than by Western endoscopists (P < .001). Limitations: Low response rate, heterogeneity of the sample, and recall bias. Conclusions: The opinions and clinical practice patterns for the management of anticoagulation and antiplatelet medications differed significantly between Eastern and Western endoscopists. The lack of uniformity in practice patterns suggests that more data and better education are required in the area of GI endoscopy for patients on anticoagulation and antiplatelet medications, particularly given that individual patient characteristics may be associated with unique types of complications.",
author = "Lee, {Sun Young} and Tang, {Shou jiang} and Rockey, {Don C.} and Douglas Weinstein and Luis Lara and Jayaprakash Sreenarasimhaiah and Choi, {Kyoo Wan}",
year = "2008",
month = "6",
doi = "10.1016/j.gie.2007.11.037",
language = "English (US)",
volume = "67",
pages = "1076--1081",
journal = "Gastrointestinal Endoscopy",
issn = "0016-5107",
publisher = "Mosby Inc.",
number = "7",

}

TY - JOUR

T1 - Managing anticoagulation and antiplatelet medications in GI endoscopy

T2 - a survey comparing the East and the West

AU - Lee, Sun Young

AU - Tang, Shou jiang

AU - Rockey, Don C.

AU - Weinstein, Douglas

AU - Lara, Luis

AU - Sreenarasimhaiah, Jayaprakash

AU - Choi, Kyoo Wan

PY - 2008/6

Y1 - 2008/6

N2 - Background: Anticoagulation and antiplatelet medications may potentiate GI bleeding, and their use may lead to an increased need for a GI endoscopy. We hypothesized that there might be different practice patterns among international endoscopists. Objective: To explore the differences in management practices for patients who receive anticoagulation and antiplatelet medications from Eastern and Western endoscopists. Design: International survey study. Setting: Academic medical centers and private clinics. Subjects: Members of the American Society for Gastrointestinal Endoscopy (ASGE) in Eastern (Korea, Japan, China, India, Thailand, Singapore, Malaysia, and Philippines) and Western (United States and Canada) countries were invited to complete a Web-site-based questionnaire. In addition, the questionnaire was sent to university hospitals in South Korea and academic institutions in the United States. Methods: A survey was administered that contained detailed questions about the use of an endoscopy in patients on anticoagulation and antiplatelet medications. Main Outcome Measurements: Different opinions and clinical practice patterns regarding the use of anticoagulation and antiplatelet medications by Eastern and Western endoscopists. Results: A total of 105 Eastern and 106 Western endoscopists completed the survey. Western endoscopists experienced more instances of procedure-related bleeding (P = .003) and thromboembolism after withdrawal of medications (P = .016). Eastern endoscopists restarted medications later (1-3 days) than Western endoscopists after a biopsy (same day) (P < .001). Eastern endoscopists withdrew aspirin for more than 7 days before a polypectomy and then restarted it 1 to 3 days after a polypectomy, whereas Western endoscopists performed a polypectomy without withdrawing aspirin (P < .001). ASGE guidelines were followed less often by Eastern than by Western endoscopists (P < .001). Limitations: Low response rate, heterogeneity of the sample, and recall bias. Conclusions: The opinions and clinical practice patterns for the management of anticoagulation and antiplatelet medications differed significantly between Eastern and Western endoscopists. The lack of uniformity in practice patterns suggests that more data and better education are required in the area of GI endoscopy for patients on anticoagulation and antiplatelet medications, particularly given that individual patient characteristics may be associated with unique types of complications.

AB - Background: Anticoagulation and antiplatelet medications may potentiate GI bleeding, and their use may lead to an increased need for a GI endoscopy. We hypothesized that there might be different practice patterns among international endoscopists. Objective: To explore the differences in management practices for patients who receive anticoagulation and antiplatelet medications from Eastern and Western endoscopists. Design: International survey study. Setting: Academic medical centers and private clinics. Subjects: Members of the American Society for Gastrointestinal Endoscopy (ASGE) in Eastern (Korea, Japan, China, India, Thailand, Singapore, Malaysia, and Philippines) and Western (United States and Canada) countries were invited to complete a Web-site-based questionnaire. In addition, the questionnaire was sent to university hospitals in South Korea and academic institutions in the United States. Methods: A survey was administered that contained detailed questions about the use of an endoscopy in patients on anticoagulation and antiplatelet medications. Main Outcome Measurements: Different opinions and clinical practice patterns regarding the use of anticoagulation and antiplatelet medications by Eastern and Western endoscopists. Results: A total of 105 Eastern and 106 Western endoscopists completed the survey. Western endoscopists experienced more instances of procedure-related bleeding (P = .003) and thromboembolism after withdrawal of medications (P = .016). Eastern endoscopists restarted medications later (1-3 days) than Western endoscopists after a biopsy (same day) (P < .001). Eastern endoscopists withdrew aspirin for more than 7 days before a polypectomy and then restarted it 1 to 3 days after a polypectomy, whereas Western endoscopists performed a polypectomy without withdrawing aspirin (P < .001). ASGE guidelines were followed less often by Eastern than by Western endoscopists (P < .001). Limitations: Low response rate, heterogeneity of the sample, and recall bias. Conclusions: The opinions and clinical practice patterns for the management of anticoagulation and antiplatelet medications differed significantly between Eastern and Western endoscopists. The lack of uniformity in practice patterns suggests that more data and better education are required in the area of GI endoscopy for patients on anticoagulation and antiplatelet medications, particularly given that individual patient characteristics may be associated with unique types of complications.

UR - http://www.scopus.com/inward/record.url?scp=44349142750&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=44349142750&partnerID=8YFLogxK

U2 - 10.1016/j.gie.2007.11.037

DO - 10.1016/j.gie.2007.11.037

M3 - Article

C2 - 18384789

AN - SCOPUS:44349142750

VL - 67

SP - 1076

EP - 1081

JO - Gastrointestinal Endoscopy

JF - Gastrointestinal Endoscopy

SN - 0016-5107

IS - 7

ER -